Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01991210
Title A Randomized Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Genentech, Inc.

ovary epithelial cancer

peritoneum cancer

fallopian tube cancer



Pegylated liposomal-doxorubicin

Age Groups: adult
Covered Countries USA | FRA | ESP | CAN | BEL

No variant requirements are available.